ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.Learn more about ZooMAb here.
Synonyms: JV18-1; MAD homolog 2; Mad-related protein 2; Mothers against DPP homolog 2; Mothers against decapentaplegic homolog 2; SMAD family member 2; hMAD-2; hSMAD2
Storage: 2-8C
Application: Immunocytochemistry Analysis: A 1:100 dilution from a representative lot detected phospho-Smad2 (Ser465/467) in HepG2 treated with TGF-beta (5 ng/mL for 2 hrs).Immunohistochemistry (Paraffin) Analysis: A 1:200 and 1:100 dilution from a representative lot detected phospho-Smad2 (Ser465/467) in human breast cancer and human colon cancer tissue sections.Peptide Inhibition Analysis: A 1:1,000 dilution from a representative lot was used with HeLa cells treated with TGF-beta for peptide block analysis.
Legal Information: ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany